NFATc3 is required for chronic hypoxia-induced pulmonary hypertension in adult and neonatal mice

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 301, Issue 6, 2011, Pages

  Bierer, R ^a   Nitta, C H ^a   Friedman, J ^a   Codianni, S ^a   de Frutos, S ^a   Dominguez Bautista, J A ^a   Howard, T A ^a   Resta, T C ^a   Gonzalez Bosc, L V ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Arterial remodeling; Nuclear factor of activated t cells reporter activity; Pulmonary arterial endothelial cells; Pulmonary arterial smooth muscle; Right ventricular hypertrophy

Indexed keywords

TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTERIAL WALL THICKNESS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HEART RIGHT VENTRICLE HYPERTROPHY; HYPOXIA; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANOXIA; APOPTOSIS; CELL NUCLEUS; CELL PROLIFERATION; GENE KNOCKOUT TECHNIQUES; GENES, REPORTER; HETEROZYGOTE; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; LUCIFERASES; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; NFATC TRANSCRIPTION FACTORS; PROTEIN TRANSPORT; PULMONARY ARTERY;

EID: 82855169252     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00405.2010     Document Type: Article

References (37)

1. Abbott KL, Loss JR, Robida AM, Murphy TJ. Evidence that Galpha(q)-coupled receptor-induced interleukin-6 mRNA in vascular smooth muscle cells involves the nuclear factor of activated T cells. Mol Pharmacol 58: 946-953, 2000.
2. Ambalavanan N. Endothelin-A receptor blockade inhibits the effects of hypoxia on the newborn lung vasculature. ScientificWorldJournal 6: 669-670, 2006.
3. Ambalavanan N, Li P, Bulger A, Murphy-Ullrich J, Oparil S, Chen YF. Endothelin-1 mediates hypoxia-induced increases in vascular collagen in the newborn mouse lung. Pediatr Res 61: 559-564, 2007.
4. Ambalavanan N, Nicola T, Hagood J, Bulger A, Serra R, Murphy-Ullrich J, Oparil S, Chen YF. Transforming growth factor-beta signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung. Am J Physiol Lung Cell Mol Physiol 295: L86-L95, 2008.
5. Ambalavanan N, Bulger A, Murphy-Ullrich J, Oparil S, Chen YF. Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling. Pediatr Res 57: 631-636, 2005.
6. Ambalavanan N, Nicola T, LI P, Bulger A, Murphy-Ullrich J, Oparil S, Chen YF. Role of matrix metalloproteinase-2 in newborn mouse lungs under hypoxic conditions. Pediatr Res 63: 26-32, 2008.
7. Amberg GC, Rossow CF, Navedo MF, Santana LF. NFATc3 regulates Kv2.1 expression in arterial smooth muscle. J Biol Chem 279: 47326-47334, 2004.
8. Bonnet S, Rochefort G, Sutendra G, Archer SL, Haromy A, Webster L, Hashimoto K, Bonnet SN, Michelakis ED. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted. Proc Natl Acad Sci U S A 104: 11418-11423, 2007.
9. Chicoine LG, Avitia JW, Deen C, Nelin LD, Earley S, Walker BR. Developmental differences in pulmonary eNOS expression in response to chronic hypoxia in the rat. J Appl Physiol 93: 311-318, 2002.
10. De Frutos S, Duling L, Alo D, Berry T, Jackson-Weaver O, Walker M, Kanagy N, Gonzalez Bosc L. NFATc3 is required for intermittent hypoxia-induced hypertension. Am J Physiol Heart Circ Physiol 294: H2382-H2390, 2008.
11. De Frutos S, Nitta CH, Caldwell E, Friedman J, Gonzalez Bosc LV. Regulation of soluble guanylyl cyclase-_1 expression in chronic hypoxiainduced pulmonary hypertension: role of NFATc3 and HuR. Am J Physiol Lung Cell Mol Physiol 297: L475-L486, 2009.
12. De Frutos S, Ramiro-Diaz JM, Nitta CH, Sherpa ML, Gonzalez Bosc LV. Endothelin-1 contributes to increased NFATc3 activation by chronic hypoxia in pulmonary arteries. Am J Physiol Cell Physiol 301: C441-C450, 2011.
13. De Frutos S, Spangler R, Alo D, Gonzalez Bosc LV. NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling with alpha-actin up-regulation. J Biol Chem 282: 15081-15089, 2007.
14. Fike CD, Kaplowitz MR. Effect of chronic hypoxia on pulmonary vascular pressures in isolated lungs of newborn pigs. J Appl Physiol 77: 2853-2862, 1994.
15. Gomez MF, Stevenson AS, Bonev AD, Hill-Eubanks DC, Nelson MT. Opposing Actions of inositol 1,4,5-trisphosphate and ryanodine receptors on nuclear factor of activated t-cells regulation in smooth muscle. J Biol Chem 277: 37756-37764, 2002.
16. Gonzalez Bosc LV, Layne J, Nelson MT, Hill-Eubanks DC. Nuclear factor of activated T-cells and serum response factor cooperatively regulate an α-actin intronic enhancer. J Biol Chem 280: 26113-26120, 2004.
17. Gonzalez Bosc LV, Wilkerson MK, Bradley KN, Eckman DM, Hill-Eubanks DC, Nelson MT. Intraluminal pressure is a stimulus for NFATc3 nuclear accumulation-role of calcium, endothelium-derived nitric oxide, and cGMP-dependent protein kinase. J Biol Chem 279: 10702-10709, 2004.
18. Graef IA, Chen F, Chen L, Kuo A, Crabtree GR. Signals transduced by Ca(2_)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 105: 863-875, 2001.
19. Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17: 2205-2232, 2003.
20. Hopkins N, McLoughlin P. The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis? J Anat 201: 335-348, 2002.
21. Kegley KM, Gephart J, Warren GL, Pavlath GK. Altered primary myogenesis in NFATC3(_/_) mice leads to decreased muscle size in the adult. Dev Biol 232: 115-26, 2001.
22. Latini G, Del VA, De FC, Verrotti A, Bossone E. Persistent pulmonary hypertension of the newborn: therapeutical approach. Mini Rev Med Chem 8: 1507-1513, 2008.
23. McNamara PJ, Murthy P, Kantores C, Teixeira L, Engelberts D, van Vliet T, Kavanagh BP, Jankov RP. Acute vasodilator effects of Rhokinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide. Am J Physiol Lung Cell Mol Physiol 294: L205-L213, 2008.
24. Molkentin JD, Dorn IG2. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63: 391-426, 2001.
25. Nieves-Cintron M, Amberg GC, Nichols CB, Molkentin JD, Santana LF. Activation of NFATC3 down-regulates the beta 1 subunit of large conductance, calcium-activated K_ channels in arterial smooth muscle and contributes to hypertension. J Biol Chem 282: 3231-3240, 2006.
26. Paddenberg R, Stieger P, von Lilien AL, Faulhammer P, Goldenberg A, Tillmanns HH, Kummer W, Braun-Dullaeus RC. Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice. Respir Res 8: 15, 2007.
27. Rabinovitch M. Cell-extracellular matrix interactions in the ductus arteriosus and perinatal pulmonary circulation. Semin Perinatol 20: 531-541, 1996.
28. Rabinovitch M, Gamble W, Nadas AS, Miettinen OS, Reid L. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol Heart Circ Physiol 236: H818-H827, 1979.
29. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15: 707-747, 1997.
30. Snow JB, Kitzis V, Norton CE, Torres SN, Johnson KD, Kanagy NL, Walker BR, Resta TC. Differential effects of chronic hypoxia and intermittent hypocapnic and eucapnic hypoxia on pulmonary vasoreactivity. J Appl Physiol 104: 110-118, 2008.
31. Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 99: 675-691, 2006.
32. Steudel W, Scherrer-Crosbie M, Bloch KD, Weimann J, Huang PL, Jones RC, Picard MH, Zapol WM. Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest 101: 2468-2477, 1998.
33. Stevenson AS, Gomez MF, Hill-Eubanks DC, Nelson MT. NFAT4 movement in native smooth muscle. A role for differential Ca(2+) signaling. J Biol Chem 276: 15018-15024, 2001.
34. Weitzenblum E, Chaouat A, Canuet M, Kessler R. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases. Semin Respir Crit Care Med 30: 458-470, 2009.
35. Wohrley JD, Frid MG, Moiseeva EP, Orton EC, Belknap JK, Stenmark KR. Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media. J Clin Invest 96: 273-281, 1995.
36. Young KC, Torres E, Hatzistergos KE, Hehre D, Suguihara C, Hare JM. Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxiainduced pulmonary hypertension. Circ Res 104: 1293-1301, 2009.
37. Ziino A, Ivanovska J, Belcastro R, Kantores C, Xu E, Lau M, McNamara PJ, Tanswell AK, Jankov RP. Effects of Rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia. Pediatr Res 67: 177-182, 2010.